Multidisciplinary Approach and Therapeutic Innovation

The Dermatological Oncology Unit has established itself as a reference in the comprehensive management of skin cancer, adopting a patient-centered multidisciplinary approach. Our care model is based on close collaboration among dermatologists, medical oncologists, plastic surgeons, pathologists, radiation therapists, psychologists, and specialized nursing staff, which allows us to offer highly individualized therapies tailored to the clinical and molecular characteristics of each case.

One of our main areas of focus is immunotherapy, a therapeutic strategy that has transformed the prognosis of many skin tumors, such as advanced melanoma and squamous cell carcinomas, by enhancing the immune system's ability to fight tumor cells. We combine these treatments with other innovative options to maximize efficacy and minimize side effects, including various radiotherapy treatments.

Additionally, we are strongly committed to clinical research, actively participating in the development of clinical trials that enable our patients to access cutting-edge therapies and contribute to scientific advancement. This research activity not only improves therapeutic outcomes but also broadens treatment possibilities in early and advanced stages of the disease.

The unit also pays special attention to the treatment of physical and emotional sequelae resulting from both the tumor and its treatments. Reconstructive interventions, rehabilitation therapies, and psycho-oncological support are essential parts of our approach, aiming to improve patients' quality of life in the short and long term.

Our commitment is clear: to provide excellent care based on personalization, innovation, and comprehensive support for each person affected by skin cancer